Authors

• Zouina Sarfraz, Wertheim Cancer InstituteFollow
• Lydia Hodgson, Wertheim Cancer InstituteFollow
• Arun Maharaj, Wertheim Cancer InstituteFollow
• Reshma Mahtani, Wertheim Cancer InstituteFollow
• Manmeet Ahluwalia, Wertheim Cancer InstituteFollow

Survival outcomes with trastuzumab deruxtecan in HER2-positive vs. HER2-low breast cancer patients with brain metastases: a real-world cohort study

Publication Date

2026

Content Type

article

PubMed ID:

42203808

Additional Authors:

Additional Authors and Institutional Affiliations

Citation

Scientific Reports (2026) [Epub ahead of print] Published online: May 27